PHYTOCHEMICAL AND ANTIMICROBIAL SCREENING OF THE STEM BARK EXTRACTS) OF INDIGOFERA ARRECTA HOCHST EX A. RICH(FABACEAE)
Table Of Contents
- Title pageAbstractTable of contentsList of abbreviationsCHAPTER ONE1.0 Introduction1.1 Definition of a drug1.2 Medicinal plants1.3 Medicinal plant research1.4 Aim1.
- 4.1Objectives1.5 Scope and limitations of research1.6 Justification of the researchCHAPTER TWO2.0 Literature review2.1 Botanical description of the genus Indigofera arrecta2.
- 1.1Other botanical information2.
- 1.2Origin and geographical distribution2.2 Chemical constituents of indigofera arrecta2.
- 2.1Traditional medicinal uses2.
- 2.2Uses of some of the genus2.3 Production and international trade2.
- 3.1Pharmacological properties2.
- 3.2Adulterations and substitutes2.
- 3.3Growth and development2.
- 3.4Ecology2.
- 3.5Management2.
- 3.6Propagation and planting2.
- 3.7Diseases and pests2.
- 3.8Harvesting2.
- 3.9Yield2.4 Handling after harvest2.
- 4.1General description of Indigofera arrecta (HOCHST EX.A.RICH )
- 2.5Review of some natural products from plants, tests and their uses2.5.1Alkaloids2.5.2Flavonoids2.
- 5.3Saponins2.
- 5.4Glycosides2.
- 5.5Tannins2.
- 5.6Steroids2.5.
- 7.Terpenoids2.6 Factors which can affect the level or the composition of the active ingredients in medicinal plant2.7 Some microorganisms and their effects on the human body2.
- 7.1Staphylococci2.
- 7.2Streptococci2.
- 7.3Candida2.
- 7.4Enterobacteriaceae2.
- 7.5Klebsiella2.
- 7.6Escherichia coli2.
- 7.7SalmonellaeCHAPTER THREE3.0 Materials and method3.1 Materials/reagents/equipment and analytical procedure3.
- 1.1Solvents3.
- 1.2Equipment3.
- 1.3Reagent3.
- 1.4Microbial media, test organisms and equipment for antimicobial test3.
- 1.5The identification and preparation of plant material3.
- 1.6Extraction procedure for crude extract3.2 Preliminary phytochemical screening3.
- 2.1Test for steroids/terpenes3.
- 2.2Test for flavonoids3.
- 2.3Test for alkaloids3.
- 2.4Test for tannins3.
- 2.5Test for anthraquinones3.
- 2.6Test for saponins3.
- 2.7Test for glycoside (fecl3 test)
- 3.3Antimicrobial screening3.
- 3.1Preparation of bacterial test organisms3.
- 3.2Preparation of fungal test organisms3.
- 3.3The stock dilution of the plant extracts3.
- 3.4Preparation of the nutrient agar3.
- 3.5Preparation of the sabouraud dextrose agar media3.
- 3.6The punched agar diffusion method [bryant, 1972]3.
- 3.7Preparation of inoculums of test organisms3.
- 3.8Sensitivity test of the extract using agar diffusion method3.
- 3.9Determination of minimum inhibitory concentration using tube dilution method3.4 Minimum bactericidal concentration (mbc)3.
- 4.1Chromatographic purification of extracts3.
- 4.2Thin layer chromatography (TLC)3.
- 4.3Column chromatography3.
- 4.4Solvents system/elution3.
- 4.5Gel filtration chromatography3.
- 4.6Thin layer chromatography of the n-hexane extract3.
- 4.7Column chromatography of n-hexane fractionCHAPTER FOUR4.0 Results4.1 Result of extraction4.2 Result of phytochemical screening4.3 Results of antimicrobial activity4.4 Result of chromatographic separation4.5 Column chromatography of n-hexane fraction4.6 Isolation of EB4.7 TLC analysis of EB4.8 Result of antimicrobial activity of compound EBCHAPTER FIVE5.0 Discussion of result5.1 Extraction5.2 Phytochemical screening5.3 Antimicrobial screening5.4 Physical and chemical properties of EB5.
- 4.1Spectral analysis5.
- 4.2FTIR5.
- 4.31H NMR5.
- 4.413C NMR5.
- 4.5DEPTCHAPTER SIX6.0 Summary, conclusion and recommendation6.
- 1.Summary6.2 Conclusion6.3 RecommendationReferencesLIST OF ABBREVIATIONcm Centimetercm-1 Per centimeterHz Hertzml Milliliternm Nanometerppm Parts per millionUV Ultra violetIR Infraredλmax Wavelength of maximum absorptionTLC Thin layer chromatographyδ Chemical shift in ppms Singletd Doubletdd Double doubletMHz Megahertz% PercentageRf Retardation factorHMBC Heteronuclear multiple bond correlationHSQC Homonuclear single quantum coherenceCOSY Correlation spectroscopyDEPT Distortionless enhancement by polarization transferMIC Minimum inhibitory concentrationMBC Minimum bactericidal concentration
Project Abstract
The Pulverized stem bark of Indigofera arrecta was exhaustively extracted with methanol and concentrated in vacuo using rotary evaporator at 40 0C.The extract was later subjected to solvent partitioning to yield soluble extracts of n-hexane, ethyl acetate, chloroform, and methanol. General phytochemical screening of the fractions revealed the presence of secondary metabolites such as cardiac glycoside,steroid, terpenes flavonoids and tannins. The antimicrobial activity against S. aureus,S. pyogenes,S.faecalis, S.typhi, E.coli C. ulcerans,P. vulgaris and C.albicans was tested using the tube dilution and agar diffusion methods as outlined by the NCCLS. The results of the antimicrobial activity as indicated by the zones of inhibition of growth of microorganism ranged from 20mm to 40mm for the n-hexane extract, 16mm to 21mm for ethyl acetate extract and 20mm to 27mm for the methanol extract. The MIC result for the n-hexane, ethyl acetate and methanol extracts ranged from 7.5mg/ml to 15mg/ml. The MIC of 15mg/ml exhibited by the n-hexane extract against both gram positive and gram negative bacteria indicates broad spectrum activity of Indigofera arrecta. The n-hexane fractions was subjected to Column Chromatography using silica gel to yield 87 fractions, which were combined based on their thin layer chromatography analysis and recrystallized in methanol to give a pure white crystalline powder, which melts at 144oC. The structure of the isolated compound was established by spectroscopic analysis and by direct comparison of the data obtained with those reported in literature to be Stigmasterol (3β,22E-Stigmasta-5,22-dien-3-ol).
Project Overview
1.0 INTRODUCTION1.1 Definition of a drugA drug can be described as any chemical substance that has no nutritional value when introduced into the body but causes some physiological effects within the system (Mbah, 2000). Drugs are classified under pharmaceuticals. Pharmaceutical drug, according to Dey (2006), also refers to as medicine or medicament, can be loosely defined as any substance intended for use in the diagnosis, cure, mitigation, treatment or prevention of diseases.Some pharmaceuticals occur naturally in plants. These can be called phyto pharmaceuticals. By the strictest definition, they are drugs or chemicals that may have health related effects but are not considered essential nutrients. Protein, carbohydrates, fats, minerals and vitamins are regarded as essential nutrients. Some pharmaceuticals found in plants include gedunin and nimbolide from Azadirachta indica (Neem) (Khalid and Duddeck, 1993); santonin, a sesquiterpenoid lactone is found in species of Artemisia which grows in Asia, quinine and alkaloid occurs in the bark of cinchona tree; penincillin- a beta-lactam is produced by fungi in the genus Penicillium (Finar, 2003) and reserpine-an alkaloid is isolated from Rauwolfia plant.1.2 Medicinal plantsAccording to biblical records, Prophet Ezekiel reported that the fruits will serve as food and their leaves for healing (Ezekiel 47:12). Thus, the use of plants for medicinal purposes dates back to thousands of years ago as the earliest humans used various plants to treat illness (Dey, 2006). Medicinal plants or healing herbs, as they are called, are used in treating and preventing specific ailments and diseases and as such are considered to play a beneficial role in health care.Srivastava et al., (1996) earlier stated that hundreds of plant species are recognized as having medicinal values and four out of every five of those plants are collected from the wild forest while most are from the flora of developing countries. The medicinal properties or values may be present in one or all the plants parts like roots, stem, back, leaves, flower, fruit or seeds.In fact, with all the progress in synthetic chemistry and biotechnology, plants are still indispensable source of drugs and natural products on the basis of their therapeutics (Lawn, 1993).Some common medicinal plants that occur in our locality include Azadirachta indica (Neem), Ocimum gratissimum persea americana, Vernonia amygdalina, Alstonia boonei, Zanthoxylum gilletii and Buchholzia coriacea among others.1.3 Medicinal plant researchThe efficacy of these medicinal plants is based on the presence of secondary metabolites which belong to a group of compounds called natural products. Natural products are those chemical compounds derived from living organisms, plants, animals, insects and the study of natural products is the investigation of their structure formation, applications and purpose in the organisms. The drugs or active ingredients derived from natural products are usually secondary metabolites, for example, terpenes, flavonoids, saponins and alkaloids and their derivatives. Today, these compounds must be pure and highly characterized compounds through scientific research.Medicinal plant research starts by people carrying out general screening of plants which are collected either randomly or based on local reputations as medicinal plants after botanically identified by a reputable authority or plant taxonomist. This screening consists mainly of solvent extraction and standard tests of the extracts for the presence of such class of compounds or secondary metabolites as alkaloids, saponins and phenolic compounds. This in itself may not lead to the discovery of any new biologically active compound if carried out competently and consistently but it could provide data from which plants with potential biological activity could be selected for further detailed study (Adjanohoun et al., 1991,Farnsworth,1996).The extracts are then fractionated with a view of isolating pure compounds. Modern isolation techniques include all types of chromatography often guided by bioassays to isolate the active compounds. The chromatographic procedures include absorption and partition chromatography in columns, thin layer and recently high performance liquid Chromatography. The structures of the isolatein modern times are elucidated primarily by spectroscopic techniques. The compounds can be identified as already known compounds or entirely new compounds.1.3.1 AIM1. The aim of this work was to justify or otherwise the claimed ethnomedicinal uses of the plant1.3.2 OBJECTIVESI. Collection, proper botanical identification, drying and pulverizing of the plant.II. Extraction of the powdered plant material using different solvents based on the elutropic series i.e from non-polar to most polar.III.The extract of this plant would be subjected to phytochemical and antimicrobial screeningIV. Analytical separations involving several consecutive steps of chromatographic techniques.V. Structural elucidation of the isolated compound(s) using spectral techniques1.4:SCOPE AND LIMITATION OF THE RESEARCHThe scope of this research work would be:1. The phytochemical screening, antibacterial, antifungal screening, isolation, characterization and structural elucidation of the active principles of Indigofera arrecta.1.5 JUSTIFICATION OF THE RESEARCHThe need to know the active ingredients in the stem of Indigofera arrecta which are responsible for the cure/treatment of various ailments such as epilepsy, sores treatment, diarrhea and ulcer and to have scientific evidence of the claims of the ethnomedicinal practices of the stem of Indigofera arrecta.